Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
Starting Oct. 1, 2025, Trump proposes 100% tariffs on imported branded drugs unless made in U.S. plants.
Starting October 1, 2025, Trump announced a 100% tariff on imported branded and patented pharmaceuticals unless manufacturers are actively building U.S. production facilities, defined as breaking ground or under construction.
The move, framed as a national security and economic protection measure, aims to boost domestic manufacturing and reduce reliance on foreign supply chains.
Exempt from the tariff are companies already constructing U.S. plants, while generic drugs are not affected.
The policy is part of a broader set of proposed tariffs on goods like kitchen cabinets, upholstered furniture, and heavy trucks.
The announcement triggered declines in Asian stock markets and raised concerns about higher drug prices, supply chain disruptions, and global trade tensions.
A partir del 1 de octubre de 2025, Trump propone aranceles del 100% a los medicamentos de marca importados a menos que se fabriquen en plantas estadounidenses.